On the financial calendar for Carter's, Inc. (NYSE: CRI), a prominent date has been set: June 9, 2023. This is the record date for the company's next dividend payout, where Carter's is expected to pay a dividend of $0.75 per share. For shareholders, it's an occasion of note, and for prospective investors, it's a deadline to consider. This article analyzes Carter's recent earning results and the implications of its forthcoming dividend.
Dividend Details
The company declared a dividend of $0.75 per share with the ex-dividend date falling on May 26, 2023. This date is crucial for investors, as anyone purchasing Carter's stock on or after the ex-dividend date will not be entitled to receive this forthcoming dividend payment. Instead, the dividends would revert to the seller. Hence, interested buyers looking forward to securing the upcoming dividend must ensure their stocks are purchased before this ex-dividend date.
Comparatively, the last dividend payout by Carter's was also $0.75 per share, which took place on March 17, 2023. It is encouraging to see that the company is maintaining its dividend payout, which could indicate stability in its financial health.
Earnings Analysis
While dividends are often a sign of financial health, they aren't the whole story. To understand the full financial picture, it's essential to consider Carter's recent earnings results. As of my knowledge cutoff in September 2021, the specific earnings details are not available, however, investors should analyze the most recent earnings report, considering metrics such as revenue, net income, earnings per share (EPS), and guidance for future quarters.
Stability or growth in these areas could indicate that Carter's can comfortably afford its dividend payout without compromising its operations or growth investments. Conversely, if these metrics show signs of strain, the steady dividend might be a cause for concern, suggesting that the company is returning cash to shareholders instead of investing in potentially profitable areas.
The declaration of a consistent dividend by Carter's paints a picture of a company with stable financial footing, at least superficially. But, prospective investors should not use this information in isolation. Alongside this dividend analysis, investors should dig deeper into Carter's earnings reports to get a holistic understanding of the company's financial status.
While the dividend payout is an excellent return for current shareholders, potential investors should make their move before the ex-dividend date if they aim to enjoy this financial perk. Regardless, a thorough understanding of the company's overall financial health will serve as the best guide for investment decisions.
CRI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 40 cases where CRI's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CRI's RSI Oscillator exited the oversold zone, of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on April 01, 2025. You may want to consider a long position or call options on CRI as a result. In of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for CRI just turned positive on March 17, 2025. Looking at past instances where CRI's MACD turned positive, the stock continued to rise in of 57 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CRI advanced for three days, in of 321 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 61 cases where CRI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for CRI entered a downward trend on March 26, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.694) is normal, around the industry mean (3.964). P/E Ratio (13.718) is within average values for comparable stocks, (110.742). CRI's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.444). Dividend Yield (0.036) settles around the average of (0.028) among similar stocks. P/S Ratio (1.063) is also within normal values, averaging (1.139).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CRI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of apparel and related products for babies and young children
Industry ApparelFootwearRetail